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Introduction 
Newts: Notophthalmus viridescens, the 
red-spotted newt, is an animal model used 
for its remarkable regenerative 
capabilities.  
Regeneration: Whole organs and body 
parts can be regenerated after removal. 
One particular example that is used in the 
present study is lens regeneration. Lens is 
regenerated after removal from the dorsal 
iris and never from the ventral iris.  
Regeneration and cancer: Interestingly, it 
has been shown that newt tissues that 
undergo regeneration are resistant to 
carcinogens. Ventral iris regenerate the 
lens after treatment with carcinogens. The 
process involves the production of a new 
functional lens and not the formation of a 
tumor which is characterized mainly of 
cells with uncontrolled cell division. This 
study aims to study this phenomenon. 
Methodology 
• Primary dorsal and ventral iris pigmented 
epithelial cell (PEC) culture. 
• Transfection with pSV3neo; an 
expression vector of simian virus 40 Large 
T antigen (LTA), a protein commonly used 
to immortalize cells. 
• Select PEC that are positive for LTA 
using G418, a selection marker for PECs 
transfected with the vector. 
• Transplant immortal PECs to a recipient 
newt and observe the effect.  
Results 
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Discussion 
Future directions 
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The antibody against LTA stains all  positive 
cells as indicated in the positive control. The 
transfection efficiency with control vector 
expressing GFP is low (10%). The efficiency 
with pSV3neo is even lower (0.01%). That 
indicates that pSV3neo can not drive expression 
of LTA in our cells and, in combination with the 
low efficiency of transfection, the number of 
positive cells are drastically reduced. In addition, 
as indicated with bright field imaging, PECs are 
resistant in the selection marker G418 that our 
vector expresses, thus, making propagation of 
LTA positive cells difficult. G418 also prevents 
the formation of lentoids. 
Since pSV3neo can not drive LTA expression 
sufficiently, a new vector will be used which a) 
has a promoter known to drive expression in 
these cells b) expressing Xrel3 which has been 
shown to create tumors in frogs c) the protein is 
fused with tomato, a red-fluorescent protein for 
live imaging of positive cells.  
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